Although we have learned so much about genetics in the past few decades, there is still a lot of information we don’t know. And unfortunately, the amount of information we don’t know is greater for some groups of people than for others.
While hereditary cancer screening panels have allowed individuals to broaden the scope of testing, a lack of guidelines for moderate and low risk genes can leave some patients unsure about next steps.
Advancements in technology has created a resurgence around gene therapy which is now offering new hope for Spinal Muscular Atrophy testing.
When a sequence of base pairs on a DNA or RNA strand matches the same sequence of base pairs, they are considered palindromic.